2YP.F HEALTH CATALYST INC.
- Market cap
- EUR 101M
- P/E
- -
- P/B
- 0.79x
- ROE
- -101.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 2YP.F undervalued?
Graham numberThe Graham number of HEALTH CATALYST INC. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
HEALTH CATALYST INC. fundamental analysis
No fundamental analysis for HEALTH CATALYST INC. yet.
HEALTH CATALYST INC. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About HEALTH CATALYST INC.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face acros…
Full company profileHEALTH CATALYST INC. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
HEALTH CATALYST INC. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 242M | 276M | 296M | 307M | 311M | 263M |
| Gross Profit | 118M | 133M | 132M | 141M | 152M | 126M |
| Operating Income | -144M | -140M | -100.0M | -57.6M | -42.7M | -43.1M |
| EBITDA | - | -91.7M | -57.8M | -10.7M | -103M | -89.2M |
| Net Income | -153M | -137M | -118M | -69.5M | -178M | -148M |
| EPS | -2.91 | -2.49 | -2.03 | -1.09 | -2.47 | -1.94 |
| Balance Sheet | ||||||
| Total Assets | 832M | 752M | 702M | 859M | 503M | 237M |
| Total Liabilities | 310M | 327M | 335M | 494M | 257M | 91.8M |
| Shareholders' Equity | 522M | 425M | 367M | 365M | 246M | 146M |
| Cash & Short-term Investments | 193M | 116M | 106M | 250M | 50.8M | 53.7M |
| Cash Flow | ||||||
| Operating Cash Flow | -23.1M | -35.3M | -33.1M | 14.6M | 731K | 22.5M |
| Capital Expenditure | 18.5M | 17.4M | 14.3M | 16.4M | 21.6M | 20.4M |
| Free Cash Flow | -41.6M | -52.7M | -47.4M | -1.84M | -20.8M | 2.11M |
| Ratios | ||||||
| ROE | -29.3% | -32.3% | -32.2% | -19.0% | -72.4% | -101.7% |
| ROA | -18.4% | -18.3% | -16.8% | -8.1% | -35.4% | -62.4% |
| Net Profit Margin | -63.3% | -49.7% | -39.9% | -22.7% | -57.2% | -56.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
HEALTH CATALYST INC. dividends
HEALTH CATALYST INC. has not paid dividends in the last 5 fiscal years.
Who owns HEALTH CATALYST INC.
- Insiders 9.44%
- Institutions 70.48%
- Public & others 20.08%
- Shares outstanding 76.2M
- Free float 60.2M
HEALTH CATALYST INC. company profile
- Company name
- HEALTH CATALYST INC.
- Ticker
- 2YP.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 1,200
- Fiscal year end
- December
- Address
- 10897 South River Front Parkway, South Jordan, UT, United States, 84095
- Phone
- 801 708 6800
- Website
- healthcatalyst.com
About HEALTH CATALYST INC.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
HEALTH CATALYST INC. management
10- Mr. Jason AlgerChief Financial Officer · born 1984
- Mr. Benjamin LandryGeneral Counsel & Secretary of the Board · born 1982
- Mr. Benjamin AlbertChief Business Officer · born 1973
- Mr. Simeon M. KohlCEO, President, Principal Executive & Operating Officer and Director · born 1967
- Ms. Stephanie St. ClairSenior Vice President of Finance & Investor Relations
- Mr. Kyle J. SalyersChief Strategy Officer & Senior VP of Corporate Development
- Ms. Carrie Kozlowski OTChief Marketing Officer
- Becky VeaChief Human Resources Officer
- Mr. Jeffrey P. SelanderSenior Vice President of International
- Ms. Holly RimmaschSenior VP & Chief Clinical Officer